stockrowBio-Rad Laboratories, Inc. (BIO.B) vs Glaukos Corporation (GKOS)
- Bio-Rad Laboratories, Inc. BIO.B 379.50 +4.22%
- Glaukos Corporation GKOS 223.67 +1.68%
Bio-Rad Laboratories, Inc. and Glaukos Corporation are both Medical Devices companies. Glaukos Corporation is the larger, with a market value of $13.0B against $10.3B — 1.3× the size. Glaukos Corporation has negative trailing earnings, so its P/E is not meaningful; Bio-Rad Laboratories, Inc. trades at 9.9×. Glaukos Corporation grew revenue faster over the last twelve months: 46.9% against 1.38%. Bio-Rad Laboratories, Inc. has the higher net margin (39.5% vs −24.6%) and the higher return on invested capital (−0.44% vs −24.6%). Across the 20 metrics below, Bio-Rad Laboratories, Inc. leads on 14 and Glaukos Corporation on 6.
Valuation
Profitability
| Metric | BIO.B | GKOS | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.26% | 81.13% | 57.76% |
| Operating margin | (2.39%) | (25.52%) | (15.07%) |
| Net margin | 39.45% | (24.60%) | (14.45%) |
| Free cash flow margin | 18.05% | 5.22% | (3.88%) |
| Return on equity | 14.27% | (22.84%) | (10.35%) |
| Return on assets | 9.99% | (17.16%) | (17.26%) |
| Return on invested capital | (0.44%) | (24.60%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack